Company: MDXG
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0001376339-25-000048
Chunk: 97

Company: MIMEDX GROUP, INC.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 97
---
|-------:|:----|:--|--------:|
| Net Income                                                            |     | $                       | 42,419 |     | $ |  58,228 |
| Non-GAAP Adjustments:                                                 |     |                         |        |     |   |         |
| Depreciation expense                                                  |     |                         |  2,279 |     |   |   2,665 |
| Amortization of intangible assets                                     |     |                         |  3,762 |     |   |     762 |
| Interest expense, net                                                 |     |                         |  1,006 |     |   |   6,457 |
| Income tax provision                                                  |     |                         | 15,296 |     |   | -39,780 |
| Share-based compensation                                              |     |                         | 16,933 |     |   |  17,178 |
| Investigation, restatement and related expenses                       |     |                         | -8,698 |     |   |   5,176 |
| Impairment of intangible assets                                       |     |                         |    446 |     |   |       — |
| Transaction related expenses                                          |     |                         |    612 |     |   |       — |
| Strategic legal and regulatory expenses                               |     |                         |  2,806 |     |   |       — |
| Expenses related to disbanding of Regenerative Medicine Business Unit |     |                         |   -421 |     |   |   6,384 |
| Reorganization expenses                                               |     |                         |      — |     |   |   1,412 |
| Adjusted EBITDA                                                       |     | $                       | 76,440 |     | $ |  58,482 |

#### Adjusted Gross Profit and Adjusted Gross Margin
Adjusted Gross Profit is calculated as GAAP Gross Profit less Amortization of Acquired Intangible Assets. Adjusted Gross Margin is calculated as Adjusted Gross Profit divided by GAAP Net Sales.

We use Adjusted Gross Profit and Adjusted Gross Margin provide important information reflecting the financial performance of our core manufacturing operations.

<div align='center'>A-1</div>

The following table reconciles GAAP Gross Profit to Adjusted Gross Profit (amounts in thousands):

|                                            |     | For the year ended December 31, |    2024 |   |     |   |    2023 |   |
|: